Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $848.91 | 46 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $360.49 | 21 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $157.42 | 5 | $0 (2024) |
| ABBVIE INC. | $131.45 | 11 | $0 (2024) |
| Alkermes, Inc. | $60.93 | 3 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $53.12 | 1 | $0 (2024) |
| Lundbeck LLC | $38.78 | 2 | $0 (2024) |
| ITI, Inc. | $32.05 | 2 | $0 (2023) |
| Axsome Therapeutics, Inc. | $14.67 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $735.17 | 39 | Janssen Pharmaceuticals, Inc ($278.80) |
| 2023 | $113.74 | 7 | Janssen Pharmaceuticals, Inc ($81.69) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/15/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: CNS | ||||||
| 11/13/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Neuroscience | ||||||
| 11/08/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $8.81 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: CNS | ||||||
| 10/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $98.77 | General |
| Category: PSYCHIATRY | ||||||
| 10/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $82.48 | General |
| Category: Neuroscience | ||||||
| 10/23/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Neuroscience | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.13 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Neuroscience | ||||||
| 09/20/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Neuroscience | ||||||
| 09/20/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $1.76 | General |
| Category: Neuroscience | ||||||
| 09/19/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $53.12 | General |
| Category: Neurology | ||||||
| 08/28/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: Neuroscience | ||||||
| 08/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.95 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $40.05 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: PSYCHIATRY | ||||||
| 07/17/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Neuroscience | ||||||
| 07/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.41 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $18.73 | General |
| Category: PSYCHIATRY | ||||||
| 06/19/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 45 | 67 | $3,781 | $2,807 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 32 | 54 | $2,789 | $2,093 | 75.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 13 | 13 | $991.90 | $714.45 | 72.0% |
About Tina Mcdyess, PHD
Tina Mcdyess, PHD is a Psychiatric/Mental Health healthcare provider based in Ellisville, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2022. The National Provider Identifier (NPI) number assigned to this provider is 1689393407.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tina Mcdyess, PHD has received a total of $848.91 in payments from pharmaceutical and medical device companies, with $735.17 received in 2024. These payments were reported across 46 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($848.91).
As a Medicare-enrolled provider, Mcdyess has provided services to 45 Medicare beneficiaries, totaling 67 services with total Medicare billing of $2,807. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Ellisville, MS
- Active Since 08/24/2022
- Last Updated 06/12/2023
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1689393407
Products in Payments
- INVEGA SUSTENNA (Drug) $360.49
- CAPLYTA (Drug) $189.47
- VRAYLAR (Drug) $131.45
- UZEDY (Drug) $53.12
- LYBALVI (Drug) $38.89
- ARISTADA (Drug) $22.04
- ABILIFY MAINTENA (Drug) $20.05
- ABILIFY ASIMTUFII (Drug) $18.73
- Auvelity (Drug) $14.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.